from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0054/ssb

LFCtreatmentdescriptionclass of inhibitor

1.616

Amikacinug/mL Amikacintranslation

2.179

Cap5-10ug/mL Capreomycintranslation

3.451

Rox10-50 ug/mL Roxithromycintranslation

0.007

SM2-5 ug/mL Streptomycintranslation

3.587

Tet5-10 ug/mL Tetracyclinetranslation

0.329

Rif0.2-5ug/mL Rifampicintranscription

-0.005

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.577

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.600

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.484

CPZ10-50 ug/mL Chlorpromazinerespiration

0.475

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.307

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.470

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.115

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.854

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.133

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.112

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.660

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.214

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.014

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.371

KCN5-20 ug/mL Potassium cyaniderespiration

-0.645

NaN30.2-2 mM Sodium aziderespiration

0.154

Nigericin50 uM Nigericinrespiration

-0.178

TRC10-150 ug/mL Triclosanrespiration

0.084

TRZ10-25 ug/mL Thioridazinerespiration

-0.547

Valinomycin0.5-10 uM Valinomycinrespiration

-0.582

ZnSO42 mM ZnSO4respiration

-0.250

menadione6-10 ug/mL Menadionerespiration

-1.221

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.328

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.555

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.695

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.413

NRP_1Non-replicating persistence stage 1dosRassociated

-0.413

Amp0.2mg/mL AmpicillincellWall

-0.137

Cephalexin20-100 ug/mL CephalexincellWall

-0.118

Cerulenin0.32-5 ug/mL CerulenincellWall

0.542

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.107

EMB10-20 ug/mL EthambutolcellWall

-0.060

Eta12-40 ug/mL EthionamidecellWall

0.169

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.470

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.353

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.175

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.531

BZA0.12 mg/mL BenzamidearomaticAmides

0.397

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.178

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.137

H2O24 mM hydrogen peroxideDNAdamaging

1.364

Levo10 ug/mL LevofloxacinDNAdamaging

0.630

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.586

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.688

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.534

UVUV-irradiationDNAdamaging

-0.115

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.672

Antimycin12.5-50 ug/mL Antimycin A?

-0.264

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.122

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.955

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.797

PA8240.2-2 ug/mL PA-824?

-0.666

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.313

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.928

Verapamil50 uM Verapamil?

-0.519

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.465

methoxatin10-20 ug/mL Methoxatin?